Largest Life Sciences Tools & Services Companies By Total Asset

Total Asset
Total AssetEfficiencyMarket RiskExp Return
1TMO Thermo Fisher Scientific
97.32 B
 0.10 
 2.34 
 0.23 
2IQV IQVIA Holdings
26.9 B
 0.13 
 3.13 
 0.40 
3ICLR ICON PLC
16.88 B
 0.11 
 3.67 
 0.39 
4RVTY Revvity
12.39 B
 0.00 
 2.62 
 0.00 
5AVTR Avantor
12.11 B
(0.01)
 3.27 
(0.03)
6A Agilent Technologies
11.85 B
 0.07 
 2.05 
 0.14 
7BIO Bio Rad Laboratories
9.36 B
 0.10 
 3.27 
 0.33 
8CRL Charles River Laboratories
7.53 B
 0.19 
 3.28 
 0.62 
9ILMN Illumina
6.3 B
 0.17 
 2.68 
 0.44 
10BRKR Bruker
5.81 B
(0.06)
 3.82 
(0.22)
11QGEN Qiagen NV
5.69 B
 0.22 
 1.29 
 0.29 
12WAT Waters
4.55 B
(0.10)
 2.62 
(0.26)
13FTRE Fortrea Holdings
3.58 B
 0.03 
 6.49 
 0.19 
14MTD Mettler Toledo International
3.24 B
 0.10 
 2.18 
 0.22 
15SHC Sotera Health Co
3.07 B
(0.11)
 1.91 
(0.20)
16RGEN Repligen
2.83 B
(0.05)
 2.84 
(0.13)
17TECH Bio Techne Corp
2.7 B
 0.09 
 2.74 
 0.24 
18MEDP Medpace Holdings
2.1 B
 0.11 
 7.29 
 0.82 
19AZTA Azenta Inc
2.1 B
 0.15 
 2.91 
 0.43 
20PACB Pacific Biosciences of
1.26 B
 0.07 
 6.02 
 0.44 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value. Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.